{"id":60420,"date":"2024-02-28T06:48:16","date_gmt":"2024-02-28T06:48:16","guid":{"rendered":"https:\/\/medsname.com\/riscon\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"riscon","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/riscon\/","title":{"rendered":"Riscon"},"content":{"rendered":"

<\/p>\n

\n

⚡ Quick Answer — What is Riscon?<\/h3>\n
\n

Riscon<\/strong> bevat risperidone<\/strong> from a WHO-GMP certified manufacturer (Sun Pharma) — one of the most-prescribed atypical antipsychotics<\/strong> worldwide. FDA-approved for schizophrenia (adults and adolescents 13+), bipolar mania (adults and ages 10+), and irritability in autism (children 5+). Mechanism: tight D2<\/sub> + 5-HT2A<\/sub> antagonism. Standard adult dose: 2–6 mg\/day<\/strong> (start 0.5–1 mg, titrate gradually). Distinctive side effects<\/strong>: highest hyperprolactinaemia<\/strong> of the atypicals (galactorrhoea, gynaecomastia, amenorrhoea, sexual dysfunction); EPS at doses > 6 mg\/day (atypical \u2192 typical “crossover” behaviour); moderate metabolic burden. FDA black box for elderly dementia mortality<\/strong>.<\/p>\n<\/div>\n

\nWat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde klantbeoordelingen<\/a>\n<\/div>\n

\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n

Waarom bestellen bij MedsBase<\/h3>\n

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n<\/div>\n

Important — this is not a situational-anxiety medication.<\/strong> Riscon is a atypical antipsychotic<\/strong>, prescribed and titrated over weeks for schizophrenia, bipolar mania, and irritability associated with autistic disorder in children<\/strong>. It is niet<\/strong> the right drug for acute, performance-related anxiety (flying, public speaking, exams) — for those use cases beta-blockers (propranolol), benzodiazepines, or hydroxyzine are clinically appropriate. If you do not have a diagnosed mood, anxiety, or psychiatric disorder, do not start this medication.<\/div>\n
FDA black-box warning — elderly dementia mortality.<\/strong> All antipsychotics (atypical and conventional) carry an FDA black-box warning for increased mortality when used to treat dementia-related psychosis or behavioural disturbance in elderly patients. This medication is niet goedgekeurd<\/strong> for dementia-related symptoms.<\/div>\n

What Is Riscon?<\/h2>\n

Riscon is an oral tablet of risperidone<\/strong> manufactured by Sun Pharma. Risperidone (US brand Risperdal<\/strong>) was launched by Janssen in 1993 and is one of the most-prescribed atypical antipsychotics globally. It is a tight D2<\/sub> en 5-HT2A<\/sub> -antagonist<\/strong> with additional alpha-1, alpha-2, and H1<\/sub> blockade. Tighter D2<\/sub> binding than other atypicals means risperidone behaves more like a first-generation antipsychotic at higher doses — with EPS risk above 6 mg\/day. The active metabolite paliperidone (9-OH-risperidone) drives much of the clinical effect and is itself marketed separately as Invega.<\/p>\n

Goedgekeurde indicaties<\/h2>\n